Otros idiomas Cumberland Pharmaceuticals Inc.

Acciones

CPIX

US2307701092

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 06/05/2024			Varia. Cinco días.	Varia. 1 de enero.
1,53 ^USD	-3,16 %		-9,73 %	-14,61 %

05/03	Cumberland Pharmaceuticals Inc. informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
05/03	Transcript : Cumberland Pharmaceuticals Inc., 2023 Earnings Call, Mar 05, 2024

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS	30/04
NEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE ACROSS PATIENT POPULATIONS	02/04
Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	13/03
Cumberland Pharmaceuticals : CEO Message	12/03
Cumberland Pharmaceuticals : CEO Message	05/03
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Cumberland: Q4 Earnings Snapshot	05/03
Cumberland Pharmaceuticals Reports Annual 2023 Financial Results	05/03
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL RESULTS	27/02
Cumberland Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Cumberland: Q3 Earnings Snapshot	07/11
Cumberland Pharmaceuticals Seeks Acquisitions	07/11
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 EPS $0.02	07/11
Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Reports Q3 Revenue $10.1M	07/11
Cumberland Pharmaceuticals Reports Third Quarter 2023 Financial Results	07/11
Tranche Update on Cumberland Pharmaceuticals Inc.'s Equity Buyback Plan announced on May 13, 2010.	07/11
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS	31/10/23
NEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN PATIENTS 2 TO 17 YEARS OF AGE	10/10/23
Cumberland Pharmaceuticals Inc. Announces New Antimicrobial Agents and Chemotherapy Detaining the Results of the First Clinical Study Investigating the Safety and Pharmacokinetics of Vibativ®? Injection in Children 2 to 17 Years of Age	10/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Cumberland Pharmaceuticals Inc.

Acciones

CPIX

US2307701092

Otros idiomas

Filtros